For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, in part because clinicians have limited tools to guide individualized ...

Mike Francisco was an athletic 35-year-old Phoenix medical professional when he was diagnosed with late-stage colon cancer. His story is not unusual.

The GPS Mdx test is a 17-gene expression assay performed on prostate biopsy tissue that may identify signals of favorable vs unfavorable pathology.

In this episode of The OncoloGIST, breast cancer oncologist and clinical researcher Dr Paolo Tarantino of Dana-Farber Cancer Institute reflects on how antibody-drug conjugates (AD ...

The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how effectively the two are integrated.

For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, in part because clinicians have limited tools to guide individualized ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...

CAMBRIDGE, England and MONTREAL, March 19, 2026 /PRNewswire/ -- CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre (R) Lung ...

L1, EBV and mismatch repair deficiency suggests CLDN18.2 stratification must be integrated into multi-biomarker algorithms rather than used in isolation. Treatment interactions emerged: CLDN18.2-high ...

Genetic assays have transformed how clinicians approach treatment decisions in breast cancer, offering both predictive and prognostic insight that helps tailor therapy to individu ...

Don’t wait.”  March is Colorectal Cancer Awareness Month. MedStar Health recently conducted a national survey to learn what people know about colon health:  * 77% do not know the correct age for when ...

Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...